ALTx Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $17M

  • Investors
  • 3

ALTx Therapeutics General Information

Description

Developer of oncology therapeutics intended to support the treatment of cancers associated with the alternative lengthening of telomeres (ALT) pathway. The company offers research and development of targeted cancer therapeutics focused on ALT pathway biological mechanisms and novel molecular targets, enabling oncology researchers, pharmaceutical partners, and healthcare providers to transform cutting-edge science into patient impact

Contact Information

Formerly Known As
Slingshot Altco Limited
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Burnham House, Splash Lane
  • Wyton
  • Huntingdon PE28 2AF
  • England, United Kingdom
Primary Industry
Drug Discovery
Corporate Office
  • Burnham House, Splash Lane
  • Wyton
  • Huntingdon PE28 2AF
  • England, United Kingdom

ALTx Therapeutics Timeline

2026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ALTx Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 05-Feb-2026 $17M Completed Startup
1. Spin-Off 28-Aug-2025 Completed Startup
To view ALTx Therapeutics’s complete valuation and funding history, request access »

ALTx Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed Preferred
To view ALTx Therapeutics’s complete cap table history, request access »

ALTx Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ALTx Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cancer Research Technology Venture Capital Minority
Syncona Venture Capital Minority
The Francis Crick Institute Accelerator/Incubator Minority
To view ALTx Therapeutics’s complete investors history, request access »

ALTx Therapeutics FAQs

  • When was ALTx Therapeutics founded?

    ALTx Therapeutics was founded in 2025.

  • Where is ALTx Therapeutics headquartered?

    ALTx Therapeutics is headquartered in Huntingdon, United Kingdom.

  • What is the size of ALTx Therapeutics?

    ALTx Therapeutics has 1 total employees.

  • What industry is ALTx Therapeutics in?

    ALTx Therapeutics’s primary industry is Drug Discovery.

  • Is ALTx Therapeutics a private or public company?

    ALTx Therapeutics is a Private company.

  • What is the current valuation of ALTx Therapeutics?

    The current valuation of ALTx Therapeutics is .

  • What is ALTx Therapeutics’s current revenue?

    The current revenue for ALTx Therapeutics is .

  • How much funding has ALTx Therapeutics raised over time?

    ALTx Therapeutics has raised $17M.

  • Who are ALTx Therapeutics’s investors?

    Cancer Research Technology, Syncona, and The Francis Crick Institute have invested in ALTx Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process